NCT00647153View on ClinicalTrials.gov

Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Colorectal Cancer
Interventions
OTHER

pharmacological study

Pre-infusion and 30 min., 1h,2h, and 3-4h post start of infusion. Day 1 and 2 post infusion.

PROCEDURE

single photon emission computed tomography

One day post infusion

RADIATION

iodine I 123 anti-CEA recombinant diabody T84.66

10mCi/mg

Trial Locations (1)

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT00647153 - Immunoscintigraphy Using Radiolabeled Monoclonal Antibody in Finding Tumor Cells in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter